DPHARMA - stock earnings
7148.KL Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 20, 2024 BeforeMarket | - / - | - | - / 772.1 million | - |
7148.KL Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 8.5 million MYR | 167.5 million MYR |
| 2023Q3 | 9.0 million MYR | 169.2 million MYR |
| 2023Q2 | 12.5 million MYR | 167.5 million MYR |
| 2023Q1 | 22.6 million MYR | 200.5 million MYR |
| 2022Q4 | 17.2 million MYR | 152.0 million MYR |
| 2022Q3 | 16.3 million MYR | 177.1 million MYR |
| 2022Q2 | 16.3 million MYR | 181.7 million MYR |
| 2022Q1 | 20.3 million MYR | 185.9 million MYR |
| 2021Q4 | 15.7 million MYR | 145.4 million MYR |
| 2021Q3 | 17.0 million MYR | 171.8 million MYR |
| 2021Q2 | 15.4 million MYR | 155.4 million MYR |
| 2021Q1 | 17.6 million MYR | 166.5 million MYR |
| 2020Q4 | 16.2 million MYR | 134.1 million MYR |
| 2020Q3 | 14.1 million MYR | 133.8 million MYR |
| 2020Q2 | 14.7 million MYR | 143.3 million MYR |
| 2020Q1 | 13.6 million MYR | 158.7 million MYR |
| 2019Q4 | 12.0 million MYR | 137.8 million MYR |
| 2019Q3 | 14.9 million MYR | 142.9 million MYR |
| 2019Q2 | 13.9 million MYR | 145.5 million MYR |
| 2019Q1 | 14.5 million MYR | 150.4 million MYR |
| 2018Q4 | 14.4 million MYR | 115.6 million MYR |
| 2018Q3 | 12.3 million MYR | 125.8 million MYR |
| 2018Q2 | 10.3 million MYR | 124.0 million MYR |
| 2018Q1 | 10.6 million MYR | 133.3 million MYR |
| 2017Q4 | 12.1 million MYR | 112.3 million MYR |
| 2017Q3 | 11.1 million MYR | 115.4 million MYR |
| 2017Q2 | 9.6 million MYR | 117.0 million MYR |
| 2017Q1 | 9.6 million MYR | 123.3 million MYR |
| 2016Q4 | 8.8 million MYR | 74.0 million MYR |
| 2016Q3 | 6.2 million MYR | 80.3 million MYR |
| 2016Q2 | 3.9 million MYR | 79.1 million MYR |
| 2016Q1 | 7.8 million MYR | 79.5 million MYR |
| 2015Q4 | 13.0 million MYR | 88.5 million MYR |
| 2015Q3 | 8.6 million MYR | 79.4 million MYR |
| 2015Q2 | 5.8 million MYR | 56.3 million MYR |
| 2015Q1 | 9.0 million MYR | 45.6 million MYR |
| 2014Q4 | 10.7 million MYR | 51.0 million MYR |
| 2014Q3 | 8.7 million MYR | 44.8 million MYR |
| 2014Q2 | 7.5 million MYR | 40.6 million MYR |
| 2014Q1 | 8.4 million MYR | 40.5 million MYR |
| 2013Q4 | 8.1 million MYR | 45.7 million MYR |
| 2013Q3 | 6.8 million MYR | 40.8 million MYR |
| 2013Q2 | 10.7 million MYR | 38.0 million MYR |
| 2013Q1 | 6.7 million MYR | 37.8 million MYR |
| 2012Q4 | 6.0 million MYR | 35.4 million MYR |
| 2012Q3 | 6.4 million MYR | 29.5 million MYR |
| 2012Q2 | 6.9 million MYR | 34.4 million MYR |
| 2012Q1 | 6.7 million MYR | 36.1 million MYR |
7148.KL Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 52.6 million MYR | 704.7 million MYR |
| 2022 | 70.1 million MYR | 696.7 million MYR |
| 2021 | 65.7 million MYR | 639.2 million MYR |
| 2020 | 58.6 million MYR | 569.9 million MYR |
| 2019 | 55.3 million MYR | 576.5 million MYR |
| 2018 | 47.6 million MYR | 498.7 million MYR |
| 2017 | 42.5 million MYR | 468.0 million MYR |
| 2016 | 26.8 million MYR | 312.9 million MYR |
| 2015 | 36.4 million MYR | 269.8 million MYR |
| 2014 | 35.3 million MYR | 177.0 million MYR |
| 2013 | 32.3 million MYR | 162.4 million MYR |
| 2012 | 26.0 million MYR | 135.3 million MYR |
| 2011 | 26.7 million MYR | 138.1 million MYR |
| 2010 | 28.7 million MYR | 131.4 million MYR |
| 2009 | 30.2 million MYR | 123.8 million MYR |
| 2008 | 27.4 million MYR | 122.9 million MYR |
| 2007 | 32.0 million MYR | 115.6 million MYR |
| 2006 | 29.0 million MYR | 105.1 million MYR |
7148.KL
Price: MYR1.30
Dividend Yield: 1.92%
Forward Dividend Yield: 2.86%
Payout Ratio: 72.00%
Dividend Per Share: 0.04 MYR
Earnings Per Share: 0.05 MYR
P/E Ratio: 24.80
Exchange: KLS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: -8.19%
DGR5: 8.86%
DGR10: -0.51%